Latest News
Conference Coverage
Aducanumab continues to rack up positive numbers in phase 1b open-label extension
BOSTON – Data at 3 years support the relative safety of aducanumab in patients with prodromal or mild Alzheimer’s.
Latest News
More physicians excluded from MIPS under final CMS rule
The “increase in the low-volume threshold is expected to exclude 540,000 clinicians who do not exceed” that threshold.
From the Journals
Early diagnosis of tuberous sclerosis may be possible in infants
An echocardiogram and skin examination can help diagnose TSC before the onset of epilepsy.
Latest News
In Lewy body disease, CSF may reveal dementia risk
SAN DIEGO – A small study showed that levels of tau protein and amyloid-beta in the cerebrospinal fluid correlated with postmortem findings of...
Conference Coverage
Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentum
BOSTON – Researchers are increasing the doses of two antiamyloid drugs in new and existing Alzheimer’s trials based on data from extension studies...
Conference Coverage
VIDEO: Smartphones could ‘democratize’ EEG
SAN DIEGO – Further refinements to a smartphone EEG system could bring diagnostic capabilities to poor and underserved areas of the world.
Feature
Government uncertainty drives jump in ACA silver plan insurance premiums
Expected premium changes are highly variable by state, with Iowa seeing an increase of 69% for its silver plans, while Alaska expecting a 22%...
Latest News
AMA: Patient mix has become less uninsured since 2012
Most of the improvement concentrated in states that expanded Medicaid.
From the Journals
Early referral recommended for high-risk port-wine stain cases
MRI is expensive and early negative scans may not be able to exclude Sturge-Weber syndrome.
Conference Coverage
New narcolepsy drug passes phase 3 test
SAN DIEGO – Solriamfetol improved sleepiness scores, compared with placebo, and may have a low addiction risk.
Conference Coverage
AF patients without oral anticoagulation face higher dementia risk
BARCELONA – Large Swedish study provides one more reason to start anticoagulation early and stick with it.